ONO-4538 Phase II Rollover Study (ONO-4538-98) (clinicaltrials.gov) - Oct 15, 2026 - P2 | N=70 | Recruiting | Sponsor: Ono Pharmaceutical Co., Ltd. | Trial completion date: Dec 2026 ➔ Dec 2027 | Trial primary completion date: Dec 2026 ➔ Dec 2027
Monotherapy • Pan tumor • Trial completion date • Trial primary completion date • Oncology
|